ACURA PHARMACEUTICALS, INC 4
4 · ACURA PHARMACEUTICALS, INC · Filed Dec 20, 2010
Insider Transaction Report
Form 4
REDDICK ANDREW D
DirectorPresident and CEO
Transactions
- Award
Stock Options
2010-12-16+83,333→ 83,333 totalExercise: $3.02Exp: 2020-12-15→ Common Stock (83,333 underlying)
Footnotes (3)
- [F1]Exercise price is closing price of Issuer's common stock on December 16, 2010.
- [F2]one-twenty-fourth of shares underlying options vest and are exercisable on the last day of each month commencing December 31, 2010 and ending on November 30, 2012.
- [F3]Not Applicable.